ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/07 | 4,400 | 4,535 | 4,385 | 4,525 | +70 | +1.6% | 483,900 |
2020/08/06 | 4,555 | 4,575 | 4,440 | 4,455 | -100 | -2.2% | 365,900 |
2020/08/05 | 4,530 | 4,590 | 4,465 | 4,555 | +60 | +1.3% | 438,300 |
2020/08/04 | 4,435 | 4,530 | 4,425 | 4,495 | +125 | +2.9% | 518,100 |
2020/08/03 | 4,225 | 4,375 | 4,190 | 4,370 | +125 | +2.9% | 489,200 |
2020/07/31 | 4,350 | 4,395 | 4,245 | 4,245 | -105 | -2.4% | 563,300 |
2020/07/30 | 4,395 | 4,445 | 4,315 | 4,350 | -60 | -1.4% | 426,200 |
2020/07/29 | 4,495 | 4,530 | 4,340 | 4,410 | -80 | -1.8% | 614,600 |
2020/07/28 | 4,585 | 4,615 | 4,485 | 4,490 | -30 | -0.7% | 473,500 |
2020/07/27 | 4,515 | 4,575 | 4,455 | 4,520 | -95 | -2.1% | 698,400 |
2020/07/22 | 4,720 | 4,730 | 4,590 | 4,615 | -175 | -3.7% | 658,300 |
2020/07/21 | 4,750 | 4,795 | 4,660 | 4,790 | +55 | +1.2% | 520,900 |
2020/07/20 | 4,730 | 4,845 | 4,670 | 4,735 | +55 | +1.2% | 532,200 |
2020/07/17 | 4,660 | 4,710 | 4,640 | 4,680 | +20 | +0.4% | 462,400 |
2020/07/16 | 4,720 | 4,740 | 4,640 | 4,660 | -20 | -0.4% | 509,900 |
2020/07/15 | 4,650 | 4,710 | 4,600 | 4,680 | +45 | +1% | 333,000 |
2020/07/14 | 4,620 | 4,705 | 4,585 | 4,635 | -30 | -0.6% | 425,300 |
2020/07/13 | 4,670 | 4,670 | 4,530 | 4,665 | +25 | +0.5% | 493,800 |
2020/07/10 | 4,625 | 4,700 | 4,565 | 4,640 | -10 | -0.2% | 585,600 |
2020/07/09 | 4,705 | 4,735 | 4,595 | 4,650 | -25 | -0.5% | 674,800 |
2020/07/08 | 4,760 | 4,820 | 4,675 | 4,675 | -60 | -1.3% | 772,200 |
2020/07/07 | 4,690 | 4,815 | 4,675 | 4,735 | +35 | +0.7% | 788,800 |
2020/07/06 | 4,805 | 4,825 | 4,650 | 4,700 | -125 | -2.6% | 696,800 |
2020/07/03 | 4,770 | 4,855 | 4,705 | 4,825 | +75 | +1.6% | 459,400 |
2020/07/02 | 4,760 | 4,855 | 4,725 | 4,750 | -15 | -0.3% | 671,500 |
2020/07/01 | 4,945 | 4,950 | 4,760 | 4,765 | -175 | -3.5% | 544,500 |
2020/06/30 | 4,935 | 4,980 | 4,845 | 4,940 | +60 | +1.2% | 504,200 |
2020/06/29 | 4,960 | 5,020 | 4,880 | 4,880 | -180 | -3.6% | 705,900 |
2020/06/26 | 5,150 | 5,150 | 4,990 | 5,060 | -80 | -1.6% | 475,300 |
2020/06/25 | 5,010 | 5,160 | 5,010 | 5,140 | +100 | +2% | 402,800 |
2020/06/24 | 5,020 | 5,120 | 5,020 | 5,040 | -20 | -0.4% | 339,500 |
2020/06/23 | 5,200 | 5,200 | 5,020 | 5,060 | -100 | -1.9% | 351,700 |
2020/06/22 | 5,180 | 5,260 | 5,140 | 5,160 | -50 | -1% | 306,800 |
2020/06/19 | 5,110 | 5,220 | 5,060 | 5,210 | +70 | +1.4% | 863,800 |
2020/06/18 | 5,150 | 5,190 | 5,080 | 5,140 | +50 | +1% | 517,900 |
2020/06/17 | 5,050 | 5,130 | 5,010 | 5,090 | +70 | +1.4% | 434,400 |
2020/06/16 | 4,920 | 5,090 | 4,860 | 5,020 | +240 | +5% | 834,100 |
2020/06/15 | 5,080 | 5,160 | 4,780 | 4,780 | -370 | -7.2% | 1,286,400 |
2020/06/12 | 4,700 | 5,540 | 4,665 | 5,150 | +295 | +6.1% | 2,477,300 |
2020/06/11 | 4,915 | 5,020 | 4,835 | 4,855 | -120 | -2.4% | 839,800 |
2020/06/10 | 4,915 | 5,040 | 4,880 | 4,975 | +130 | +2.7% | 866,500 |
2020/06/09 | 4,690 | 4,870 | 4,680 | 4,845 | +130 | +2.8% | 685,000 |
2020/06/08 | 4,710 | 4,800 | 4,650 | 4,715 | +40 | +0.9% | 786,500 |
2020/06/05 | 4,670 | 4,690 | 4,585 | 4,675 | -65 | -1.4% | 616,400 |
2020/06/04 | 4,800 | 4,820 | 4,680 | 4,740 | -70 | -1.5% | 633,400 |
2020/06/03 | 4,830 | 4,875 | 4,745 | 4,810 | +35 | +0.7% | 632,300 |
2020/06/02 | 4,730 | 4,820 | 4,725 | 4,775 | +20 | +0.4% | 536,700 |
2020/06/01 | 4,885 | 4,885 | 4,710 | 4,755 | -80 | -1.7% | 662,300 |
2020/05/29 | 4,875 | 4,975 | 4,780 | 4,835 | -90 | -1.8% | 2,186,600 |
2020/05/28 | 4,925 | 4,930 | 4,795 | 4,925 | +85 | +1.8% | 886,200 |
1151~
1200
件表示中 / 2899件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,600円 | +5.0% | +1.5% | 0.00% | 16.10倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 357,000円 | +7.9% | +8.9% | 3.47% | 7.64倍 | 1.02倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 62,700円 | +21.1% | - | 0.00% | 15.57倍 | 2.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 410,900円 | +30.5% | +111.0% | 4.62% | 11.58倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 378,000円 | +14.5% | -2.3% | 2.38% | 13.83倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム